Clinical Trial Update: Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is planned to evaluate ultra-hypofractionated carbon-ion therapy for prostate cancer, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Yonsei University | Conditions: Prostate Cancer | Phase 1 | Status: NOT_YET_RECRUITING